101 – 110 of 1963
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
HER2-specific pseudomonas exotoxin a pe25 based fusions : Influence of targeting domain on target binding, toxicity, and in vivo biodistribution
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of tailored and dose-dense adjuvant chemotherapy and trastuzumab for resected HER2-positive breast cancer : Results from the phase 3 PANTHER trial
(
- Contribution to journal › Article
-
Mark
Identification and validation of VEGFR2 kinase as a target of voacangine by a systematic combination of DARTS and MSI
(
- Contribution to journal › Article
-
Mark
Barriers and facilitators for individualized rehabilitation during breast cancer treatment- A focus group study exploring health care professionals' experiences
(
- Contribution to journal › Article
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
(
- Contribution to journal › Scientific review
-
Mark
Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer
(
- Contribution to journal › Article
-
Mark
A Quantitative Analysis of the Role of Oxygen Tension in FLASH Radiation Therapy
(
- Contribution to journal › Article
-
Mark
Managing an altered social context—Patients experiences of staying away from home while undergoing proton beam therapy
(
- Contribution to journal › Article
-
Mark
Hypoxia attenuates trastuzumab uptake and trastuzumab-emtansine (T-DM1) cytotoxicity through redistribution of phosphorylated caveolin-1
(
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article